In 2001, approximately 2 million youths between the ages of 12 and 17 reported that they had tried inhalants at some time in their lives. While inhalant abuse is one of the most prevalent drug problems among young people in the
United States, relatively little research has been conducted on inhalant abuse.
To help remedy this lack of knowledge, the National Institute on Drug Abuse (NIDA) has awarded more than $2 million to fund seven grants focusing on issues related to inhalant abuse.
"Inhalants are widely abused by youngsters due to their easy accessibility through household products, as well as their low cost," says NIDA Acting Director Dr. Glen R. Hanson. "Furthermore, inhalant drug abuse poses definite
dangers to the health of young children, including cognitive, neurological and physiological disorders, and the threat of sudden death, yet there is a severe paucity of research-based information about the problem." he adds.
The new research will focus on:
- The epidemiology of inhalant abuse--the nature and extent of inhalant abuse, who is abusing them, and why, and the abuse of different types of inhalants in different age groups;
- Individual risk and protective factors related to the initiation of inhalant use;
- The effects of maternal inhalant abuse on the developing fetus; and
- The health consequences of inhalant abuse.
Awards were made to the following investigators:
- Ty Ridenuor, Washington University, Saint Louis, Missouri, Inhalant Abuse and Dependence;
- Diana H. Fishbein, RTI, Research Triangle Park, North Carolina, Precursors, Insulators, and Consequences of Inhalant Use;
- Diana J. Walker, University of Chicago, A Model of Inhalant Abuse Using Inhalant Responders;
- Samuel J. Gately, Brookhaven National Laboratory, Upton, New York, Feto-Maternal Pharmacokinetics of Abused Inhalants;
- Ruth W. Edwards, Colorado State University, Fort Collins,
Contact: Blair Gately
NIH/National Institute on Drug Abuse 5-Nov-2002Page: 1 2 Related medicine news :1
. UNH launches 2nd spinout company with NIH grants2
. Disease testing for immigrants: Discrimination disguised as public health policy3
. US FDA grants full approval to DOXIL(R) following submission of phase III data4
. Four teams awarded inaugural translational cancer research grants5
. Immigrants, beware: Living in the United States is fattening6
. Prevalence of obesity among immigrants increases with longer residency in US7
. FDA grants accelerated approval of TYSABRI, formerly antegren, for the treatment of MS8
. Dana-Farber receives CDC grants to develop health promotion/prevention programs in the work place9
. Speech recognition experts at OGI School of Science & Engineering receive nearly $700,000 in grants10
. Should compulsory screening of immigrants be part of UK public health policy?11
. NIH grants support health disparities biomedical research